{
 "generic_name": "Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered",
 "slug": "fluticasone-propionate-and-salmeterol-xinafoate-b3f1d1",
 "brand_names": [
  "Advair Hfa"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "07/27/2026",
 "first_posted": "07/27/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "GlaxoSmithKline",
   "package_ndc": "0173-0715-22",
   "presentation": "Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available."
  },
  {
   "company": "GlaxoSmithKline",
   "package_ndc": "0173-0716-22",
   "presentation": "Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available."
  },
  {
   "company": "GlaxoSmithKline",
   "package_ndc": "0173-0717-22",
   "presentation": "Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available."
  }
 ],
 "changes": []
}